Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 6/20 | 0.60 |
| ▸ | EGFR | P00533 | 4/20 | 0.60 |
| ▸ | MAPK9 | P45984 | 8/20 | 0.54 |
| ▸ | MAPK10 | P53779 | 8/20 | 0.54 |
| ▸ | MAPK8 | P45983 | 4/20 | 0.54 |
| ▸ | INSR | P06213 | 4/20 | 0.54 |
| ▸ | IGF1R | P08069 | 4/20 | 0.54 |
| ▸ | CDC7 | O00311 | 1/20 | 0.53 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.53 |
| ▸ | JAK2 | O60674 | 1/20 | 0.53 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.53 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.53 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.53 |
| ▸ | PAK4 | O96013 | 1/20 | 0.53 |
| ▸ | PIM1 | P11309 | 1/20 | 0.53 |
| ▸ | PRKACA | P17612 | 1/20 | 0.53 |
| ▸ | CDK2 | P24941 | 1/20 | 0.53 |
| ▸ | SYK | P43405 | 1/20 | 0.53 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.53 |
| ▸ | CLK2 | P49760 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1912009 | 1.00 | ALK (0.60) | ALKEGFRMAPK9MAPK10MAPK8 | |
| SCHEMBL12729791 | 0.89 | EGFR (0.54) | ALKEGFRMAPK9MAPK10MAPK8 | |
| SCHEMBL12729789 | 0.89 | EGFR (0.54) | ALKEGFRMAPK9MAPK10MAPK8 | |
| SCHEMBL12729786 | 0.85 | ALK (0.57) | ALKEGFRMAPK9MAPK10MAPK8 | |
| SCHEMBL12729799 | 0.84 | ZAP70 (0.59) | ALKEGFRINSRIGF1RZAP70 | |
| SCHEMBL1912125 | 0.84 | ZAP70 (0.59) | ALKEGFRINSRIGF1RZAP70 | |
| SCHEMBL1912045 | 0.84 | MAPK9 (0.72) | ALKEGFRMAPK9MAPK10MAPK8 | |
| SCHEMBL12729808 | 0.83 | ALK (0.64) | ALKEGFRMAPK9MAPK10MAPK8 | |
| SCHEMBL1912016 | 0.83 | ALK (0.64) | ALKEGFRMAPK9MAPK10MAPK8 | |
| SCHEMBL12780208 | 0.82 | ALK (0.46) | ALKEGFRMAPK9MAPK10MAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1660458-B1 | 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS | NOVARTIS AG (CH) | 2012-01-25 | — | — | EP | disclosed |
| EP-2287156-A1 | 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders | Novartis AG (CH) | 2011-02-23 | — | — | EP | disclosed |